Epidemiological Characterization of Drug Resistance among <i>Mycobacterium tuberculosis</i> Isolated from Patients in Northeast of Iran during 2012-2013

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">Total number of cases</td><td align="center">MDR cases</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">History of previous treatment</td><td align="center">26</td><td align="center">3 (11.53%)</td></tr><tr><td align="left">New case</td><td align="center">56</td><td align="center">1 (1.78%)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Percentage of MDR tuberculosis in new cases and patients with relapse during 2012-2013.

BioMed Research International

tab4

Table 4

Table 4: Epidemiological Characterization of Drug Resistance among <i>Mycobacterium tuberculosis</i> Isolated from Patients in Northeast of Iran during 2012-2013 

Table 4 | Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013 